{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T15:47:27Z","timestamp":1772812047805,"version":"3.50.1"},"reference-count":6,"publisher":"American Medical Association (AMA)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2021.30925","type":"journal-article","created":{"date-parts":[[2021,10,20]],"date-time":"2021-10-20T19:08:12Z","timestamp":1634756892000},"page":"e2130925","source":"Crossref","is-referenced-by-count":1,"title":["Racial and Ethnic Disparities in Rates of Invasive Secondary Breast Cancer Among Women With Ductal Carcinoma In Situ in Hawai\u02bbi"],"prefix":"10.1001","volume":"4","author":[{"given":"Linda","family":"Lindstr\u00f6m","sequence":"first","affiliation":[{"name":"Department of Oncology and Pathology, Karolinska Institutet and University Hospital, BioClinicum, Stockholm, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","published-online":{"date-parts":[[2021,10,20]]},"reference":[{"issue":"19","key":"zic210245r1","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1056\/NEJMoa1701830","article-title":"20-Year risks of breast-cancer recurrence after stopping endocrine therapy at 5 years.","volume":"377","author":"Pan","year":"2017","journal-title":"N Engl J Med"},{"issue":"6","key":"zic210245r2","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.14904","article-title":"Assessment of 25-year survival of women with estrogen receptor\u2013positive\/ERBB2\u2013negative breast cancer treated with and without tamoxifen therapy: a secondary analysis of data from the Stockholm tamoxifen randomized clinical trial.","volume":"4","author":"Dar","year":"2021","journal-title":"JAMA Netw Open"},{"key":"zic210245r3","article-title":"Racial and ethnic disparities in rates of invasive secondary breast cancer among women with ductal carcinoma in situ in Hawai?i.","author":"Taparra","journal-title":"JAMA Netw Open"},{"issue":"3","key":"zic210245r4","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1056\/NEJMoa044383","article-title":"Benign breast disease and the risk of breast cancer.","volume":"353","author":"Hartmann","year":"2005","journal-title":"N Engl J Med"},{"issue":"6","key":"zic210245r5","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.14716","article-title":"Characterization of benign breast diseases and association with age, hormonal factors, and family history of breast cancer among women in Sweden.","volume":"4","author":"Johansson","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"1","key":"zic210245r6","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s10549-016-3983-9","article-title":"Long-term outcome in young women with breast cancer: a population-based study.","volume":"160","author":"Fredholm","year":"2016","journal-title":"Breast Cancer Res Treat"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2785315\/lindstrm_2021_ic_210245_1634133709.59198.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,20]],"date-time":"2021-10-20T19:08:15Z","timestamp":1634756895000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2785315"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,20]]},"references-count":6,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.30925","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,20]]}}}